Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1997, 550-555, Vol 4, No. 5
M Trautmann, M Ruhnke, T Rukavina, TK Held, AS Cross, R Marre and C Whitfield
To provide a database for the development of an O-antigen-
polysaccharide-containing vaccine against Klebsiella spp., we examined the
O-antigen seroepidemiology of 378 Klebsiella clinical isolates collected
prospectively in two university centers. Strains were typed by competitive
enzyme-linked immunosorbent assay with rabbit antisera specific for
serogroups O1 to O12 and monoclonal antibodies (MAbs) specific for
serogroups O1, O2ab, O2ac, and the genus-specific core antigen. The numbers
of isolates (percentages) of individual O serogroups were as follows: 148
(39.2) for serogroup O1, 40 (10.6) for serogroup O2ab, 4 (1.1) for
serogroup O2ac, 89 (23.6) for serogroup O3, 2 (0.5) for serogroup O4, 32
(8.5) for serogroup O5, none for serogroups O7, O9, and O12, and 21 (5.6)
for serogroup O11. Forty-two (11.1) of the strains were non-O-typeable.
O-serogroup distributions were virtually identical between isolates from
invasive infections and those from noninvasive infections or colonizations.
A vaccine containing the O-specific polysaccharides of serogroups O1, O2ab,
O3, and O5 would cover 82% of clinically occurring O-antigen specificities.
Three hundred thirty-eight of 378 isolates (89.4%) reacted with the
genus-specific MAb V/9-5, which recognizes an epitope of the outer core
region of Klebsiella lipopolysaccharide. Antibodies directed against this
epitope may represent a further alternative for O-antigen-targeted
immunoprophylaxis of Klebsiella infections. These data support further
experimental investigations on the protective potential of O-antigen- based
vaccines and/or hyperimmune globulins in Klebsiella infection.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections
Department of Medical Microbiology and Hygiene, University of Ulm, Germany.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |